Form 4: Immunovant's Chief Technology Officer Sells Shares to Cover Tax Obligations

Jay S. Stout, Immunovant's Chief Technology Officer, sold 7,239 shares of common stock on April 24, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On April 24, 2024, Jay S. Stout, the Chief Technology Officer of Immunovant, Inc. [IMVT], sold 7,239 shares of common stock at a price of $28.9 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of 25,000 restricted stock units (RSUs) on April 17, 2024.
• The vesting was part of a grant of 100,000 RSUs awarded on April 17, 2023.
• The transaction was mandated by Immunovant's policy requiring tax obligations to be funded through a 'sell to cover' transaction.
• Following the transaction, Stout directly owns 147,739 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. The 'sell to cover' mechanism is a standard practice to manage tax obligations associated with equity compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates